Pep Guardiola must be ruthless in the transfer window this summer if he is to take Manchester City back to the top of English ...
Nuvation Bio has secured $250m in non-dilutive financing from Sagard Healthcare Partners to fully fund the commercialisation of taletrectinib in the US. The financial move will support Nuvation Bio's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback